TY - JOUR
T1 - The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations
AU - the ERAS4OLT.org Working Group: Claus Niemann, San Francisco, CA, USA; Joerg-Matthias Pollok, London, UK; Marina Berenguer, Valencia, Spain; Pascale Tinguely, London, UK; Carlo Frola, London, UK; Jonathan Potts, London, UK, Mohammad Alradhawi, London, UK;
AU - Patel, Madhukar S.
AU - Egawa, Hiroto
AU - Kwon, Yong Kyong
AU - Chok, Kenneth Siu Ho
AU - Spiro, Michael
AU - Raptis, Dimitri Aristotle
AU - Vij, Vivek
AU - Chaudhary, Abhideep
AU - Genyk, Yuri
N1 - Publisher Copyright:
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022/10
Y1 - 2022/10
N2 - Background: There continues to be debate about the lower limit of graft-to-recipient weight ratio (GRWR) for living donor liver transplant (LDLT). Objectives: To identify the lower limit of GRWR compatible with enhanced recovery after living donor liver transplant and to provide international expert panel recommendations. Data sources: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central. Methods: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies assessing how GRWR affects recipient outcomes such as small for size syndrome, other complications, patient and graft survival, and length of stay were included. Protocol registration: CRD42021260794. Results: Twenty articles were included in the qualitative synthesis, and all were retrospective observational studies. There was heterogeneity in the definition of study cohorts and key outcome measures such as small-for-size syndrome. Most studies lacked risk adjustment given limited single-center sample size. GRWR of ≥.8% is associated with enhanced recovery. Recipients of grafts with GRWR <.8%, however, were found to have similar outcomes as those with ≥.8% when appropriate consideration is made for portal flow modulation and recipient illness severity. Conclusions: GRWR ≥.8% is often compatible with enhanced recovery, but grafts <.8% can be used in selected LDLT recipients with optimal donor-recipient selection, surgical technique, and perioperative management (Quality of Evidence; Low | Grade of Recommendation; Strong).
AB - Background: There continues to be debate about the lower limit of graft-to-recipient weight ratio (GRWR) for living donor liver transplant (LDLT). Objectives: To identify the lower limit of GRWR compatible with enhanced recovery after living donor liver transplant and to provide international expert panel recommendations. Data sources: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central. Methods: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies assessing how GRWR affects recipient outcomes such as small for size syndrome, other complications, patient and graft survival, and length of stay were included. Protocol registration: CRD42021260794. Results: Twenty articles were included in the qualitative synthesis, and all were retrospective observational studies. There was heterogeneity in the definition of study cohorts and key outcome measures such as small-for-size syndrome. Most studies lacked risk adjustment given limited single-center sample size. GRWR of ≥.8% is associated with enhanced recovery. Recipients of grafts with GRWR <.8%, however, were found to have similar outcomes as those with ≥.8% when appropriate consideration is made for portal flow modulation and recipient illness severity. Conclusions: GRWR ≥.8% is often compatible with enhanced recovery, but grafts <.8% can be used in selected LDLT recipients with optimal donor-recipient selection, surgical technique, and perioperative management (Quality of Evidence; Low | Grade of Recommendation; Strong).
KW - enhanced recovery
KW - graft-to-recipient weight ratio
KW - living donor
KW - small for size
UR - http://www.scopus.com/inward/record.url?scp=85141283776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141283776&partnerID=8YFLogxK
U2 - 10.1111/ctr.14630
DO - 10.1111/ctr.14630
M3 - Article
C2 - 35258108
AN - SCOPUS:85141283776
SN - 0902-0063
VL - 36
JO - Clinical Transplantation
JF - Clinical Transplantation
IS - 10
M1 - e14630
ER -